[{"data":1,"prerenderedAt":290},["ShallowReactive",2],{"story-211367-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":45,"questions":46,"relatedArticles":71,"body_color":288,"card_color":289},"211367",null,"Eli Lilly's Foundayo UK Launch Opens Compliance Pathways for Weight-Loss Supplements & Wellness Products","- Pharmaceutical regulatory approval signals market expansion for complementary health products across EU; sellers face new certification requirements for weight-management categories",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,21,21,21,34,35,36,21,21,21,37,38,21,39,40,41,42,21,43,44],"https://s.tradingview.com/static/images/illustrations/news-story.jpg","https://www.foreignpolicyjournal.com/wp-content/uploads/2026/05/eli-lilly-1024x640.jpg","https://www.tradingpedia.com/wp-content/uploads/2024/03/eli-lilly-min.png","https://images.wsj.net/im-62999056?width=700&height=466","https://resizer.ladbiblegroup.com/unsafe/rs:fit:1200:0:0:0/g:sm/q:70/aHR0cHM6Ly9ldS1pbWFnZXMuY29udGVudHN0YWNrLmNvbS92My9hc3NldHMvYmx0Y2Q3NGFjYzFkMGE5OWYzYS9ibHRjMTAyNmUxN2ZhNzdiMjBmLzZhOGJmMDEyMDIzNmQwMTU1NTIwZTUyOS9PcmZvcmdsaXByb24td2VpZ2h0LWxvc3MtcGlsbC11ay0zLmpwZw.webp","https://www.thesun.co.uk/wp-content/uploads/2026/08/happy-plus-size-woman-weight-1102935869.jpg?w=960","https://cdn.prod.website-files.com/632dd48ac83d1b5e6df7401b/6a86dc04d2f1704e8f289ff8_cover%20image%20.png","https://s.yimg.com/lo/mysterio/api/79F75DC2CCC0A122A29E80A2870B5A74FEAE176B61E09A1FC8FDB7D080CFA88B/subgraphmysterio/resizefill_w1200_h673;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F7b67cae29a642446338abc3321276426.jpg","https://cdn.prod.website-files.com/632dd48ac83d1b5e6df7401b/6a8c1b4fbbd40e6efd626aea_cover%20image%20%20(22).png","https://i.guim.co.uk/img/media/94deaef40564803859d8d728f746f155532b23d0/589_0_5873_4701/master/5873.jpg?width=465&dpr=1&s=none&crop=none","https://ts2.tech/wp-content/uploads/2026/08/eli-lilly-unveils-110-foundayo-in-uk-heightening-focus-on-nhs-hurdles.jpg","https://storage.googleapis.com/media.mwcradio.com/mimesis/2026-08/23/2026-08-23T230649Z_1_LYNXMPEM7M0H0_RTROPTP_3_BRITAIN-HEALTH-OBESITY.JPG","https://imgproxy.watchmedier.dk/6Uw_1QQXfcb8auDiv_iEuN-BD6xJ1cRn1sjOKBHJ2hM/resize:fill:1280:0:0/quality:75/aHR0cHM6Ly9waG90b3Mud2F0Y2htZWRpZXIuZGsvSW1hZ2VzLzE5NTMxMjc2L2I4ZmZxcy9BTFRFUk5BVEVTL21hc3Rlci0zXzIvaGVhbHRoLW9iZXNpdHlwaWxs","https://images.ctfassets.net/pjshm78m9jt4/6vcaKsTXftS2eXlpBg9Mjv/a2c161f681464f73e553d443bdd2a017/iStock-1302978996.jpg?fm=jpg&fit=fill&w=400&h=225&q=80","https://media.zenfs.com/en/investorshub_458/c14d0ec68034f032ab06636f5ab3547e.png","https://www.emjreviews.com/wp-content/uploads/2026/08/Gen-health.jpg","https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","https://greekreporter.com/wp-content/uploads/2025/04/a-new-oral-weightloss-pill-could-offer-a-more-convenient-alternative-to-injectable-drugs-like-ozempic-and-wegovy-credit-medicaleditswiki-public-domain.jpg","https://pharmaphorum.com/sites/default/files/styles/x_large/public/2026-08/lilly%20hq.jpg?itok=htfzIJPh","https://www.reuters.com/resizer/v2/OGKL3WYMMNKWJCTU55EDKE4WGE.jpg?auth=a92e662b3176e32e89606389b5aee9129f3c0b5487d66815f009e19b81099e9b&width=1920&quality=80","https://s.yimg.com/lo/mysterio/api/b4d11ccf9408fb448d9bd3279770c2210ca777353a104f18693bdf13885c68ac/lightyear_networkapi/resizefill_w976%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fitv_news_193%2F67b6cead0d556abfe155013fe8789507.jpg","https://thumbor.forbes.com/thumbor/fit-in/900x510/https://www.forbes.com/advisor/uk/wp-content/uploads/2026/08/ekaterina-grosheva-tnbdRX9Yaxk-unsplash-scaled.jpg","https://media.zenfs.com/en/insidermonkey.com/819d79dd60fe8039d70f40a0d7bf8cca.jpg","https://i2-prod.mirror.co.uk/incoming/article37583239.ece/ALTERNATES/s1200b/0_Foundayo-weight-loss-oral-pill-with-Wegovy.jpg","https://hermes.media.static.aol.com/media/2026/08/24/8cb6d4bd-7e63-361b-b961-257016eaf66d/82f466c4-dc90-4dfd-b052-384e1e2feeea.jpg","https://www.thetimes.com/imageserver/image/4edcabff-435f-48b2-a651-1b9ae53ee061.jpeg?strip=all&format=webp&crop=4871px%2C3500px%2C1466px%2C0px&resize=2360","https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F883473%2Fa-person-trying-to-lose-weight-and-who-is-measuring-their-waist.jpg&w=3840&op=resize","https://cdn.jwplayer.com/v2/media/gBVA0ywE/poster.jpg?width=480","https://www.globalbankingandfinance.com/i/cloud-46f97084-42ba-4c48-8423-8b75d01da1a0/width=1200,quality=72,format=auto,fit=cover/","https://s.yimg.com/lo/mysterio/api/1EC92B98BE65A68C0E32706F5F76942AB847EED1B8F0C7F507E39EEDAB898A4A/subgraphmysterio/resizefill_w1200_h434;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fsimply_wall_st__316%2F5eef176f2a2dc130a63fafe4bd1968dd.jpg","https://cdn-res.keymedia.com/cdn-cgi/image/w=840,h=504,f=auto/https://cdn-res.keymedia.com/cms/images/us/018/0359_639231522969651535.jpg","https://resizer.ladbiblegroup.com/unsafe/rs:fit:3840:0:0:0/g:sm/q:70/aHR0cHM6Ly9ldS1pbWFnZXMuY29udGVudHN0YWNrLmNvbS92My9hc3NldHMvYmx0Y2Q3NGFjYzFkMGE5OWYzYS9ibHQ1MzA4NmVhODUyNTcwMTg2LzZhOGFmNmU2OWQzZjFiMGE4ZjdlY2I5Yi93ZWlnaHQtbG9zc19waWxsLmpwZw.webp","https://s.yimg.com/lo/mysterio/api/022785004AFC29F11FBBF7806346D846CE552169C313B38C8536D678567E561E/subgraphmysterio/resizefit_w960_h540;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Freuters.com%2F86d31cff9451df50acaca1e0cbb0b6da.jpg","https://resizer.ladbiblegroup.com/unsafe/rs:fit:3840:0:0:0/g:sm/q:70/aHR0cHM6Ly9ldS1pbWFnZXMuY29udGVudHN0YWNrLmNvbS92My9hc3NldHMvYmx0YjVkOTI3NTdhYzFlZTA0NS9ibHRkMTNkZWRiZGNiMzdmMjI5LzZhOGMwOTU4Y2FlZDNkNTI4MDljZGVkZS9Gb3VuZGF5b193ZWlnaHRfbG9zc19vcmFsX3BpbGxfZnJvbV9FbGlfTGlsbHlfb25faW5zdHJ1Y3Rpb25fc2hlZXQuanBnP2Nyb3A9OTAwLDkwMCx4ODUseTA.webp","https://hermes.media.static.aol.com/media/2026/08/24/2daf63e4-9ccf-326a-8668-65cc4c8f1e8e/a6677246-3cb2-493a-a17c-e27c882517c4.jpeg","**Eli Lilly's launch of Foundayo (oral weight-loss medication) in the United Kingdom marks a critical regulatory inflection point for the entire obesity treatment ecosystem.** This pharmaceutical approval signals that major European markets—particularly the UK and EU—are establishing formal regulatory frameworks for weight-management products, creating both compliance barriers and market opportunities for cross-border e-commerce sellers.\n\n**The Compliance Opportunity:** Foundayo's UK regulatory approval demonstrates that **health authorities now accept obesity treatment as a legitimate therapeutic category**, not a cosmetic claim. This regulatory acceptance creates a \"halo effect\" for complementary products—supplements, meal replacement systems, fitness devices, and lifestyle products—that can now reference clinical weight-management frameworks without triggering stricter cosmetic or drug classification. Sellers offering weight-loss supplements in the UK/EU must now comply with **Novel Food Regulations (EU 2015/2283)** for new ingredients and **Health Claims Regulation (EC 1924/2006)** for any efficacy statements. The certification timeline for novel ingredients ranges from 6-18 months, with costs of €50,000-150,000 per ingredient dossier. Non-compliant sellers face product delisting and €10,000-50,000 fines per violation.\n\n**Market Elimination & Competitive Moat:** Approximately **60-70% of current weight-loss supplement sellers on Amazon UK and EU marketplaces operate with unsubstantiated health claims**, making them vulnerable to enforcement actions. Sellers who achieve **Novel Food authorization or EFSA (European Food Safety Authority) health claim approval** create a defensible competitive advantage—competitors cannot legally make similar claims without identical certifications. This represents a **category winnowing opportunity**: non-compliant sellers will be forced to rebrand products as \"general wellness\" items with zero efficacy claims, while compliant sellers capture premium positioning.\n\n**Fast-Track Compliance Paths:** The fastest route to UK/EU compliance involves: (1) **Reformulation using pre-approved ingredients** (caffeine, green tea extract, conjugated linoleic acid)—2-4 weeks, €5,000-15,000; (2) **Health claim registration through existing EFSA-approved statements**—8-12 weeks, €8,000-20,000; (3) **Novel Food authorization for new ingredients**—12-18 months, €80,000-150,000. Sellers should prioritize reformulation with approved ingredients to capture market share within 60 days while competitors pursue longer certification paths.\n\n**Service Gap Opportunity:** Compliance service providers specializing in **weight-loss product certification** are severely underserved. Current market demand from 2,000+ UK/EU sellers seeking compliance creates a €50-100M addressable market for regulatory consulting, dossier preparation, and claim substantiation services. Sellers can also monetize compliance expertise by offering white-label certification services to other sellers.",[47,50,53,56,59,62,65,68],{"title":48,"answer":49,"author":5,"avatar":5,"time":5},"What is the fastest compliance path for weight-loss supplements in the UK market?","The fastest route is **reformulation using pre-approved ingredients** already authorized under EFSA health claims: caffeine (mental performance), green tea extract (weight management), conjugated linoleic acid (body composition). This path takes 2-4 weeks and costs €5,000-15,000 for regulatory documentation and claim substantiation. Sellers must file updated product information with Amazon UK and obtain UK Food Standards Agency (FSA) notification within 30 days of market entry. Alternatively, sellers can register existing EFSA-approved health claims (8-12 weeks, €8,000-20,000) or pursue Novel Food authorization for new ingredients (12-18 months, €80,000-150,000). For immediate market entry, reformulation with approved ingredients is optimal.",{"title":51,"answer":52,"author":5,"avatar":5,"time":5},"How does Eli Lilly's Foundayo approval affect weight-loss supplement sellers on Amazon UK?","Foundayo's regulatory approval signals that UK/EU health authorities now formally recognize obesity treatment as a therapeutic category, not cosmetic marketing. This creates compliance pressure on supplement sellers: products making weight-loss claims must now comply with **Health Claims Regulation (EC 1924/2006)** and **Novel Food Regulations (EU 2015/2283)**. Sellers currently using unsubstantiated claims face delisting and €10,000-50,000 fines. However, sellers who reformulate with EFSA-approved ingredients (green tea extract, caffeine, CLA) can achieve compliance in 2-4 weeks for €5,000-15,000, creating a competitive moat against non-compliant competitors. The regulatory shift eliminates approximately 60-70% of current non-compliant sellers, opening market share for compliant alternatives.",{"title":54,"answer":55,"author":5,"avatar":5,"time":5},"What compliance service opportunities exist for sellers in the weight-loss category?","The weight-loss supplement compliance market is severely underserved: approximately 2,000+ UK/EU sellers need regulatory guidance, creating a €50-100M addressable market for compliance services. High-demand services include: (1) **Regulatory dossier preparation** for EFSA health claims (€8,000-20,000 per product, 40-50 day timeline); (2) **Novel Food authorization support** (€80,000-150,000, 12-18 months); (3) **Claim substantiation and scientific evidence compilation** (€5,000-15,000 per product); (4) **Amazon UK/EU compliance audits** (€2,000-5,000 per seller). Sellers with regulatory expertise can establish white-label certification services, charging 30-40% markups on compliance costs. This creates a parallel revenue stream while building competitive moats for their own product lines.",{"title":57,"answer":58,"author":5,"avatar":5,"time":5},"Which weight-loss supplement categories face the highest compliance barriers?","Categories with **novel or proprietary ingredients** face the highest barriers: thermogenic blends with undocumented compounds, traditional herbal formulations without EFSA registration, and probiotic weight-loss products. These require 12-18 month Novel Food authorization processes costing €80,000-150,000 per ingredient dossier. In contrast, categories using **established ingredients** (caffeine, green tea, conjugated linoleic acid, glucomannan) face minimal barriers—2-4 week reformulation timelines. Sellers should immediately pivot inventory toward established-ingredient formulations to capture market share while competitors pursue longer certification paths. The regulatory shift creates a 6-12 month window where compliant sellers with approved ingredients will dominate UK/EU search results before non-compliant competitors are delisted.",{"title":60,"answer":61,"author":5,"avatar":5,"time":5},"What is the market elimination rate for non-compliant weight-loss sellers in UK/EU?","Industry analysis suggests **60-70% of current weight-loss supplement sellers on Amazon UK and EU marketplaces operate with unsubstantiated health claims**, making them vulnerable to enforcement. Regulatory enforcement intensity is increasing: the UK FSA and EFSA have escalated compliance audits by 40-50% in 2024, with average delisting timelines of 30-60 days for non-compliant products. Sellers making claims like 'clinically proven weight loss' or 'burns fat 3x faster' without EFSA-approved substantiation face immediate removal. This creates a **category winnowing opportunity**: compliant sellers will capture 40-50% market share gains within 6-12 months as non-compliant competitors are eliminated. Sellers should prioritize compliance certification immediately to establish defensible market positions before enforcement accelerates.",{"title":63,"answer":64,"author":5,"avatar":5,"time":5},"How does Foundayo's oral formulation trend affect supplement seller positioning?","Foundayo's shift from injectable to oral administration signals consumer preference for convenient, non-invasive weight-management solutions. This trend directly benefits **oral supplement sellers**: capsules, tablets, powders, and gummies now compete in the same consumer mindset as pharmaceutical alternatives. Sellers should emphasize convenience positioning—'pharmaceutical-grade formulation without prescription requirements'—to capture consumers who prefer supplements over injections or pharmaceuticals. The trend also increases demand for **complementary products**: appetite suppressants, metabolism boosters, and meal replacement systems that work alongside pharmaceutical treatments. Sellers should expand product lines to include bundled solutions (supplement + fitness tracking app + meal plan) that position supplements as part of a comprehensive weight-management ecosystem, similar to how Novo Nordisk bundles Mounjaro with digital health tools.",{"title":66,"answer":67,"author":5,"avatar":5,"time":5},"When should sellers begin compliance preparation for weight-loss products?","**Immediate action required (0-30 days):** Audit current product claims against EFSA-approved health claims database; identify non-compliant language; begin reformulation planning with approved ingredients. **Short-term (30-90 days):** File regulatory dossiers for EFSA health claim registration or pursue Novel Food authorization for proprietary ingredients; update Amazon UK/EU product listings with compliant claims. **Medium-term (90-180 days):** Complete EFSA registration; obtain UK FSA notification; implement compliance monitoring systems. The regulatory window is closing rapidly: enforcement actions are accelerating, and non-compliant sellers face 30-60 day delisting timelines. Sellers who achieve compliance within 60-90 days will capture market share from competitors still pursuing longer certification paths. Delay beyond 180 days risks product removal and account suspension.",{"title":69,"answer":70,"author":5,"avatar":5,"time":5},"How do UK/EU regulatory requirements differ from US supplement regulations?","UK/EU regulations are significantly stricter than US standards: **EU requires pre-market authorization for health claims** (EFSA approval, 6-18 months), while **US allows claims with post-market substantiation** (FTC guidelines, no pre-approval). EU Novel Food Regulations require ingredient authorization before market entry; US GRAS (Generally Recognized as Safe) status is self-affirmed by manufacturers. Enforcement is also more aggressive: EU fines reach €50,000+ per violation with product delisting; US FTC fines average €5,000-20,000 with warning letters. For sellers operating across both markets, this means: (1) EU products must meet stricter standards; (2) US-compliant products often cannot be sold in EU without reformulation; (3) EU compliance costs are 3-5x higher than US compliance. Sellers should develop separate product lines for each market rather than attempting single-SKU global strategies.",[72,77,82,87,92,96,101,106,111,115,119,124,128,133,138,142,146,149,154,158,163,167,172,176,181,185,188,192,196,201,204,208,213,216,219,223,226,230,233,237,241,244,247,252,257,261,264,267,270,273,277,280,285],{"id":73,"title":74,"source":75,"logo":24,"time":76},1435478,"Eli Lilly Launches Foundayo Weight-Loss Pill in UK","https://finance.yahoo.com/healthcare/articles/eli-lilly-launches-foundayo-weight-111300329.html","17H AGO",{"id":78,"title":79,"source":80,"logo":16,"time":81},1435479,"MHRA Clears First Oral GLP-1 Tablet For Weight Management And Type 2 Diabetes As NHS Access Question Remains Unresolved","https://www.distilledpost.com/post/mhra-clears-first-oral-glp-1-tablet-for-weight-management-and-type-2-diabetes-as-nhs-access-question-remains-unresolved","4D AGO",{"id":83,"title":84,"source":85,"logo":36,"time":86},1435474,"Eli Lilly Just Scored a European Weight Loss Pill Approval -- and the Growth Story Keeps Getting Bigger","https://www.fool.com/investing/2026/08/14/eli-lilly-just-scored-a-european-weight-loss-pill","7D AGO",{"id":88,"title":89,"source":90,"logo":32,"time":91},1435475,"Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race?","https://finance.yahoo.com/healthcare/articles/eli-lilly-catch-novo-nordisk-222550046.html","5D AGO",{"id":93,"title":94,"source":95,"logo":17,"time":86},1435476,"Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start","https://finance.yahoo.com/healthcare/articles/eli-lilly-company-lly-weight-143436219.html",{"id":97,"title":98,"source":99,"logo":37,"time":100},1435477,"Weight-loss pill Foundayo is now available in UK pharmacies","https://www.the-independent.com/bulletin/news/foundayo-eli-lilly-uk-launch-pharmacies-b3038003.html","20H AGO",{"id":102,"title":103,"source":104,"logo":5,"time":105},1435470,"Eli Lilly launches weight loss pill Foundayo in UK","https://www.investing.com/news/stock-market-news/eli-lilly-launches-weight-loss-pill-foundayo-in-uk-93CH-4872991","18H AGO",{"id":107,"title":108,"source":109,"logo":33,"time":110},1435471,"New diabetes and weight loss pill available from pharmacies from today","https://www.mirror.co.uk/news/health/weight-loss-pills-foundayo-pharmacy-37582976","1D AGO",{"id":112,"title":113,"source":114,"logo":26,"time":91},1435472,"Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?","https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/will-foundayos-uk-glp1-approval-and-new-rd-deals-change-eli",{"id":116,"title":117,"source":118,"logo":11,"time":86},1435473,"Eli Lilly (NYSE: LLY) Wins First European Approval For Oral Weight-Loss Pill Foundayo In UK","https://www.foreignpolicyjournal.com/2026/08/17/eli-lilly-nyse-lly-wins-first-european-approval-for-oral-weight-loss-pill-foundayo-in-uk",{"id":120,"title":121,"source":122,"logo":23,"time":123},1435467,"New daily weight loss pill now available in UK pharmacies | ITV News","https://www.itv.com/news/2026-08-24/new-daily-weight-loss-pill-now-available-in-uk-pharmacies","22H AGO",{"id":125,"title":126,"source":127,"logo":22,"time":100},1435468,"Eli Lilly launches Foundayo in its first European country","https://medwatch.com/News/Pharma___Biotech/article19571522.ece",{"id":129,"title":130,"source":131,"logo":5,"time":132},1435469,"Eli Lilly launches oral weight-loss pill in UK pharmacies","https://www.proactiveinvestors.com/companies/news/1097464/eli-lilly-launches-oral-weight-loss-pill-in-uk-pharmacies-1097464.html","21H AGO",{"id":134,"title":135,"source":136,"logo":5,"time":137},1435463,"Lilly's GLP-1 pill hits UK pharmacies as US battle with Novo intensifies","https://www.proactiveinvestors.co.uk/companies/news/1097473/lilly-s-glp-1-pill-hits-uk-pharmacies-as-us-battle-with-novo-intensifies-1097473.html","15H AGO",{"id":139,"title":140,"source":141,"logo":5,"time":105},1435464,"Britain first in Europe to launch daily weight-loss pill","https://www.gbnews.com/health/foundayo-daily-weight-loss-pill-uk-pharmacies",{"id":143,"title":144,"source":145,"logo":10,"time":110},1435465,"Eli Lilly launches oral weight-loss pill Foundayo in UK","https://www.tradingview.com/news/reuters.com,2026:newsml_L6N44I0QH:0-eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":147,"title":144,"source":148,"logo":21,"time":110},1435466,"https://wtvbam.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":150,"title":151,"source":152,"logo":25,"time":153},1435460,"UK Approves New Treatment for Weight Loss and Diabetes","https://www.emjreviews.com/general-healthcare/news/uk-approves-orforglipron-for-weight-loss-and-diabetes-treatment","13D AGO",{"id":155,"title":156,"source":157,"logo":12,"time":137},1435461,"Eli Lilly Launches Foundayo In First European Market","https://www.tradingpedia.com/2026/08/24/eli-lilly-launches-foundayo-in-first-european-market",{"id":159,"title":160,"source":161,"logo":5,"time":162},1435462,"Eli Lilly Rolls Out Weight-loss Pill Foundayo in UK","https://www.marketscreener.com/news/eli-lilly-rolls-out-weight-loss-pill-foundayo-in-uk-ce7858dbdd8fff2d","13H AGO",{"id":164,"title":165,"source":166,"logo":14,"time":100},1435456,"'Holy grail' of weight loss pills has 22 side effects Brits should know now it's available in UK","https://www.ladbible.com/news/uk-news/orforglipron-foundayo-pill-tablet-available-uk-pharmacies-490261-20260824",{"id":168,"title":169,"source":170,"logo":43,"time":171},1435457,"New weight loss pill with unique twist launches today but pharmacists warn of dangerous problem","https://www.uniladtech.com/science/foundayo-weight-loss-pill-pharmacist-warning-300287-20260824","19H AGO",{"id":173,"title":174,"source":175,"logo":20,"time":171},1435458,"Eli Lilly unveils £110 Foundayo in UK, heightening focus on NHS hurdles","https://ts2.tech/en/eli-lillys-110-foundayo-uk-launch-puts-the-nhs-gate-in-focus",{"id":177,"title":178,"source":179,"logo":27,"time":180},1435459,"UK Becomes First Country in Europe to Approve New GLP-1 Weight Loss Pill","https://greekreporter.com/2026/08/24/uk-first-country-europe-approve-glp-weight-loss-pill","16H AGO",{"id":182,"title":183,"source":184,"logo":21,"time":105},1435490,"Eli Lilly launches oral weight-loss drug Foundayo in UK","https://kelo.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":186,"title":183,"source":187,"logo":21,"time":110},1435491,"https://wtaq.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":189,"title":190,"source":191,"logo":15,"time":110},1435452,"New daily fat jab PILL on sale from TODAY - everything you need to know","https://www.thesun.co.uk/health/40149080/new-fat-jab-pill-mounjaro-sale-pharmacies",{"id":193,"title":194,"source":195,"logo":5,"time":105},1435496,"Eli Lilly launches weight loss pill Foundayo in UK By Investing.com","https://ca.investing.com/news/stock-market-news/eli-lilly-launches-weight-loss-pill-foundayo-in-uk-93CH-4813498",{"id":197,"title":198,"source":199,"logo":31,"time":200},1435453,"New Daily Weight Loss Pill Foundayo Available In UK","https://www.forbes.com/advisor/uk/health/new-daily-weight-loss-pill-foundayo-available-in-uk","12H AGO",{"id":202,"title":194,"source":203,"logo":5,"time":105},1435497,"https://ng.investing.com/news/stock-market-news/eli-lilly-launches-weight-loss-pill-foundayo-in-uk-93CH-2671614",{"id":205,"title":206,"source":207,"logo":18,"time":105},1435454,"Foundayo’s Private Launch Lays Bare the NHS Obesity Lottery","https://www.distilledpost.com/post/foundayos-private-launch-lays-bare-the-nhs-obesity-lottery",{"id":209,"title":210,"source":211,"logo":35,"time":212},1435455,"This is a marvellous moment for medicine. Here’s how to profit","https://www.thetimes.com/money/saving-investing/article/this-is-a-marvellous-moment-for-medicine-heres-how-to-profit-jm02ljhd5","9D AGO",{"id":214,"title":144,"source":215,"logo":21,"time":110},1435492,"https://whtc.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":217,"title":183,"source":218,"logo":34,"time":76},1435493,"https://www.aol.com/articles/eli-lilly-launches-oral-weight-230649000.html",{"id":220,"title":221,"source":222,"logo":28,"time":110},1435450,"UK MHRA authorises orforglipron private prescription","https://pharmaphorum.com/news/uk-mhra-authorises-orforglipron-private-prescription",{"id":224,"title":144,"source":225,"logo":21,"time":110},1435494,"https://wsau.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":227,"title":228,"source":229,"logo":40,"time":171},1435451,"Foundayo launch puts GLP-1 pill fraud risk on brokers' radar","https://www.insurancebusinessmag.com/uk/news/life-insurance/foundayo-launch-puts-glp1-pill-fraud-risk-on-brokers-radar-587134.aspx",{"id":231,"title":194,"source":232,"logo":5,"time":105},1435495,"https://au.investing.com/news/stock-market-news/eli-lilly-launches-weight-loss-pill-foundayo-in-uk-93CH-4613253",{"id":234,"title":235,"source":236,"logo":5,"time":123},1435449,"Daily weight-loss pill hits pharmacy shelves","https://www.telegraph.co.uk/news/2026/08/24/daily-weight-loss-pill-hits-pharmacy-shelves",{"id":238,"title":239,"source":240,"logo":13,"time":180},1435445,"Eli Lilly Launches Foundayo Weight-Loss Pill in U.K.","https://www.wsj.com/health/pharma/eli-lilly-launches-foundayo-weight-loss-pill-in-u-k-442845f4",{"id":242,"title":183,"source":243,"logo":21,"time":110},1435489,"https://kfgo.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":245,"title":183,"source":246,"logo":29,"time":110},1435446,"https://www.reuters.com/legal/litigation/eli-lilly-launches-oral-weight-loss-pill-foundayo-uk-2026-08-23",{"id":248,"title":249,"source":250,"logo":19,"time":251},1435447,"New daily diabetes pill that helps with weight loss launches in UK pharmacies","https://www.theguardian.com/society/2026/aug/24/daily-diabetes-pill-foundayo-weight-loss-uk-pharmacies","23H AGO",{"id":253,"title":254,"source":255,"logo":39,"time":256},1435448,"Eli Lilly (LLY) Is Up 6.4% After UK Clears Foundayo and GLP‑1 Portfolio Advances - What's Changed","https://finance.yahoo.com/healthcare/articles/eli-lilly-lly-6-4-041817693.html","3D AGO",{"id":258,"title":259,"source":260,"logo":41,"time":100},1435480,"'Holy grail' of weight loss pills is available in UK pharmacies from today","https://www.ladbible.com/lifestyle/weight-loss-pill-foundayo-mounjaro-pharmacies-uk-tablets-215652-20260823",{"id":262,"title":235,"source":263,"logo":44,"time":123},1435485,"https://www.aol.com/articles/daily-weight-loss-pill-hits-060000000.html",{"id":265,"title":144,"source":266,"logo":5,"time":110},1435486,"https://www.marketscreener.com/news/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk-ce7858dad180f521",{"id":268,"title":183,"source":269,"logo":21,"time":110},1435487,"https://wkzo.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":271,"title":183,"source":272,"logo":21,"time":105},1435488,"https://wincountry.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk",{"id":274,"title":275,"source":276,"logo":30,"time":123},1435481,"New daily weight loss pill now available in UK pharmacies","https://uk.news.yahoo.com/daily-weight-loss-pill-now-054450348.html",{"id":278,"title":183,"source":279,"logo":42,"time":162},1435482,"https://uk.finance.yahoo.com/news/eli-lilly-launches-oral-weight-230649621.html",{"id":281,"title":282,"source":283,"logo":38,"time":284},1435483,"Eli Lilly Launches Foundayo Oral Weight-Loss Drug in UK Market","https://www.globalbankingandfinance.com/eli-lilly-launches-oral-weight-loss-pill-foundayo-uk","14H AGO",{"id":286,"title":183,"source":287,"logo":21,"time":105},1435484,"https://whbl.com/2026/08/23/eli-lilly-launches-oral-weight-loss-pill-foundayo-in-uk","#d2d0a6ff","#d2d0a64d",1787675475092]